Eastman Chemical Faces Pricing Pressure, Currency Risks

Published 09/02/2016, 06:22 AM
Updated 07/09/2023, 06:31 AM
EMN
-
IOSP
-
IPHS_old
-
CC
-

On Sep 1, we issued an updated research report on chemical maker Eastman Chemical (NYSE:EMN) . .

Eastman Chemical’s revenues and profit slipped year over year in second-quarter 2016, hurt by lower selling prices. Adjusted earnings and sales missed the respective Zacks Consensus Estimate. The company saw lower prices across all businesses in the quarter.

Eastman Chemical, in its second-quarter call, said that it is benefiting from strong growth of its specialty products and its cost-cutting actions. However, the company is seeing increased competitive pressure and compressing olefin spreads. As such, the company sees a decline in adjusted earnings per share for 2016 that approaches 10% below adjusted earnings per share for 2015 compared with its earlier expectation of a decline of roughly 5%.

While Eastman Chemical is gaining from synergies of acquisitions, capacity additions and cost-cutting & productivity measures, it faces pricing pressure across its business segments as witnessed in the second quarter. Lower selling prices, especially in the Chemical Intermediates unit, hurt its revenues in the second quarter.

Soft pricing, in part, due to competitive pressure is affecting the company’s Chemical Intermediates segment. The company is seeing increased competitive pressure, especially from the Asia Pacific region, which is hurting prices.

Margins in the olefin business are expected to remain under pressure due to weak pricing. The depressed oil price environment and continued pressure on olefin spreads are expected to weigh on the company’s earnings in 2016. Weak methanol prices are also affecting prices for some acetyl and amines products.

Eastman Chemical also faces currency translation risks given a stronger U.S. dollar vis-à-vis a basket of currencies. Its revenues remain exposed to unfavorable currency swings. The company also faces headwind from challenging global economic conditions.

Eastman Chemical has a Zacks Rank #4 (Sell).

Stocks to Consider

Some better-ranked companies in the chemical space include The Chemours Company (NYSE:CC) , Innophos Holdings Inc (NASDAQ:IPHS) and Innospec Inc. (NASDAQ:IOSP) , all sporting a Zacks Rank #1 (Strong Buy).

Confidential from Zacks

Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>



EASTMAN CHEM CO (EMN): Free Stock Analysis Report

INNOPHOS HLDGS (IPHS): Free Stock Analysis Report

INNOSPEC INC (IOSP): Free Stock Analysis Report

CHEMOURS COMPNY (CC): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.